Cited by 24Phytochemicals and Antioxidant ActivitiesPlatelet Disorders and TreatmentsNitric Oxide and Endothelin Effects

Polyphenols: Anti-Platelet Nutraceutical?

Ludovici, Valeria, Barthelmes, Jens, Nagele, Matthias P., Flammer, Andreas J., Sudano, Isabella·2018·Current Pharmaceutical Design

Abstract

BACKGROUND: Coronary artery disease (CAD) is a disease progressing over many years. Genetic factors, as well as the exposure to risk factors, are continuously leading to endothelial dysfunction, vascular alterations and, eventually, organ damage, major cardiovascular events and deaths. Oxidative stress, platelet hyperactivity and low-grade inflammation are important modulators in this context, contributing to plaque formation. Since platelet activation plays a critical role in the development and progression of atherothrombotic events, the inhibition of platelet hyperactivity may contribute to decreased atherothrombotic risk. The consumption of bioactive foods, and plant-derived polyphenols in particular, might impart anti-thrombotic and cardiovascular protective effects. METHODS: Aim of this work is to focus on the potential of dietary derived polyphenols to reduce platelet hyperactivity or hypercoagulability in addition to discussing their possible complementary anti-platelet therapeutic potential. All the relevant publications on this topic were systematically reviewed. RESULTS: Various studies demonstrated that polyphenol supplementation affects platelet aggregation and function in vitro and in vivo, mainly neutralizing free radicals, inhibiting platelet activation and related signal transduction pathways, blocking thromboxane A2 receptors and enhancing nitric oxide production. Experimental data concerning the effect of dietary polyphenols on platelet aggregation in vivo are poor, and results are often conflicting. Only flavanols clearly mirrored in vivo showed the efficacy in vitro in modulating platelet function. CONCLUSION: Dietary polyphenols, and above all flavanols contained in cocoa and berries, reduce platelet activation and aggregation via multiple pathways. However, more controlled interventional studies are required to establish which doses are required as well as what circulating concentrations are sufficient to induce functional antiplatelet effects.

Integrity signals

Registry

Crossref · 10.2174/1381612823666171109104600

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Ludovici, V., Barthelmes, J., Nagele, M. P., Flammer, A. J., & Sudano, I.
Affiliations
  • University of Zurich (CH)
  • Cardiology, University Heart Center, University Hospital and University of Zurich, Zurich, Switzerland
Corresponding author
Sudano, Isabella
Venue
Current Pharmaceutical Design
Published
2018-04-05
Volume
24
Issue
2
Pages
146-157
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2767280722
Cited by
24
References
0
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 2
FWCI
1.37
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Funders
Coalition for Epidemic Preparedness Innovations
Topics
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
Keywords
dietary polyphenols, flavan-3-ols, platelet hyperreactivity, platelet aggregation, antiplatelet activity, coronary artery disease, atherothrombosis, Theobroma cacao, berries, oxidative stress, nitric oxide, thromboxane A2 receptor, nutraceuticals, endothelial dysfunction
MeSH terms
Animals, Humans, Platelet Aggregation, Platelet Aggregation Inhibitors, Platelet Function Tests, Platelet Activation, Dietary Supplements, Polyphenols

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review